|
AKIRIN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.535200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.211030E-01 |
| Normal-vs-Stage2 |
2.729400E-01 |
| Normal-vs-Stage3 |
3.300000E-02 |
| Normal-vs-Stage4 |
3.651400E-01 |
| Stage1-vs-Stage2 |
1.890390E-02 |
| Stage1-vs-Stage3 |
1.215780E-04 |
| Stage1-vs-Stage4 |
2.249800E-02 |
| Stage2-vs-Stage3 |
7.718200E-01 |
| Stage2-vs-Stage4 |
7.761400E-01 |
| Stage3-vs-Stage4 |
4.707000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.579400E-01 |
| Normal-vs-AfricanAmerican |
3.190000E-01 |
| Normal-vs-Asian |
6.941400E-01 |
| Caucasian-vs-AfricanAmerican |
1.358220E-01 |
| Caucasian-vs-Asian |
6.838600E-01 |
| AfricanAmerican-vs-Asian |
8.686400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.980200E-01 |
| Normal-vs-Female |
6.652000E-01 |
| Male-vs-Female |
2.814400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.192100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.505800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.707200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.893800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.545800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.323600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.018900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.838200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.096500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.094600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.667360E-01 |
| Normal-vs-Grade 2 |
7.024100E-02 |
| Normal-vs-Grade 3 |
2.819900E-02 |
| Normal-vs-Grade 4 |
3.773800E-01 |
| Grade 1-vs-Grade 2 |
6.566600E-01 |
| Grade 1-vs-Grade 3 |
3.457900E-02 |
| Grade 1-vs-Grade 4 |
5.786000E-02 |
| Grade 2-vs-Grade 3 |
3.41999999997622E-06 |
| Grade 2-vs-Grade 4 |
2.056100E-02 |
| Grade 3-vs-Grade 4 |
5.794600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.396600E-01 |
| Normal-vs-ccB subtype |
8.937800E-01 |
| ccA subtype-vs-ccB subtype |
5.397400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.389400E-01 |
| Normal-vs-N1 |
8.538400E-01 |
| N0-vs-N1 |
7.863600E-01 |
|
|
